Erschienen in:
01.10.2010 | Reviews
Physician Effectiveness in Interventions to Improve Cardiovascular Medication Adherence: A Systematic Review
verfasst von:
Sarah L. Cutrona, MD, MPH, Niteesh K. Choudhry, MD, PhD, Margaret Stedman, PhD, Amber Servi, BA, Joshua N. Liberman, PhD, Troyen Brennan, MD, JD, Michael A. Fischer, MD, MPH, M. Alan Brookhart, PhD, William H. Shrank, MD, MSHS
Erschienen in:
Journal of General Internal Medicine
|
Ausgabe 10/2010
Einloggen, um Zugang zu erhalten
Abstract
BACKGROUND
Medications for the prevention and treatment of cardiovascular disease save lives but adherence is often inadequate. The optimal role for physicians in improving adherence remains unclear.
OBJECTIVE
Using existing evidence, we set the goal of evaluating the physician’s role in improving medication adherence.
DESIGN
We conducted systematic searches of English-language peer-reviewed publications in MEDLINE and EMBASE from 1966 through 12/31/2008.
SUBJECTS AND INTERVENTIONS
We selected randomized controlled trials of interventions to improve adherence to medications used for preventing or treating cardiovascular disease or diabetes.
MAIN MEASURES
Articles were classified as either (1) physician “active”—a physician participated in designing or implementing the intervention; (2) physician “passive”—physicians treating intervention group patients received patient adherence information while physicians treating controls did not; or (3) physicians noninvolved. We also identified studies in which healthcare professionals helped deliver the intervention. We did a meta-analysis of the studies involving healthcare professionals to determine aggregate Cohen’s D effect sizes (ES).
KEY RESULTS
We identified 6,550 articles; 168 were reviewed in full, 82 met inclusion criteria. The majority of all studies (88.9%) showed improved adherence. Physician noninvolved studies were more likely (35.0% of studies) to show a medium or large effect on adherence compared to physician-involved studies (31.3%). Among interventions requiring a healthcare professional, physician-noninvolved interventions were more effective (ES 0.47; 95% CI 0.38–0.56) than physician-involved interventions (ES 0.25; 95% CI 0.21–0.29; p < 0.001). Among physician-involved interventions, physician-passive interventions were marginally more effective (ES 0.29; 95% CI 0.22–0.36) than physician-active interventions (ES 0.23; 95% CI 0.17–0.28; p = 0.2).
CONCLUSIONS
Adherence interventions utilizing non-physician healthcare professionals are effective in improving cardiovascular medication adherence, but further study is needed to identify the optimal role for physicians.